Publications
-
Planavila A, Rodríguez-Calvo R, Jové M, Michalik L, Wahli W, Laguna JC and Vazquez M.
Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes.
CARDIOVASCULAR RESEARCH . 65(4): 832-841. Number of citations: 156
-
Planavila A, Laguna JC and Vazquez M.
Atorvastatin improves peroxisome proliferator-activated receptor signaling in cardiac hypertrophy by preventing nuclear factor-kappa B activation.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS . 1687(1-3): 76-83. Number of citations: 86
-
Llaverias G, Vazquez M, Sánchez RM, Noé V, Ciudad CJ, Laguna JC and Alegret M.
Rosiglitazone upregulates caveolin-1 expression in THP-1 cells through a PPAR-dependent mechanism.
JOURNAL OF LIPID RESEARCH . 45(11): 2015-2024. Number of citations: 60
-
Sanguino E, Roglans N, Alegret M, Sánchez RM, Vazquez M and Laguna JC.
Prevention of age-related changes in rat cortex transcription factor activator protein-1 by hypolipidemic drugs.
BIOCHEMICAL PHARMACOLOGY . 68(7): 1411-1421. Number of citations: 16
-
Sanguino E, Bejarano R, Alegret M, Sánchez RM, Vazquez M and Laguna JC.
Sexual dimorphism in lipid metabolic phenotype associated with old age in Sprague-Dawley rats.
EXPERIMENTAL GERONTOLOGY . 39(9): 1295-1306. Number of citations: 18
-
Vazquez M and Silvestre JS.
Insulin analogues in the management of diabetes.
Methods And Findings In Experimental And Clinical Pharmacology . 26(6): 445-461. Number of citations: 27
-
Llaverias G, Lacasa D, Viñals M, Vazquez M, Sánchez RM, Laguna JC and Alegret M.
Reduction of intracellular cholesterol accumulation in THP-1 macrophages by a combination of rosiglitazone and atorvastatin.
BIOCHEMICAL PHARMACOLOGY . 68(1): 155-163. Number of citations: 29
-
Llaverias G, Noé V, Peñuelas S, Vazquez M, Sánchez RM, Laguna JC, Ciudad CJ and Alegret M.
Atorvastatin reduces CD68, FABP4, and HBP expression in oxLDL-treated human macrophages.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS . 318(1): 265-274. Number of citations: 67
-
Roglans N, Vazquez M, Alegret M, Novell F, Zambón D, Ros E, Laguna JC and Sánchez RM.
Fibrates modify the expression of key factors involved in bile-acid synthesis and biliary-lipid secretion in gallstone patients.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY . 59(12): 855-861. Number of citations: 54
-
Planavila A, Jové M, Cabrero A and Vazquez M.
Modula el metabolismo lipídico del miocardio la hipertrofia cardíaca?
Nefrologia . 24 Suppl 4: 29-33.